Transient release of IFNγ and IFNγ inducible protein 10, peaking 3–6 h post intravenous CARVac administration, was observed in serum cytokine measurements (Extended Data Fig. 2), as previously reported in patients treated with RNA-LPX mRNA cancer vaccines15. This evidence concerns the gene IFNG and cancer.